300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
InsurTech
Travel
Film
Oil and Gas
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Automotive
Medical Device
Biotechnology
eSports
Sports
Renewable Energy
Legal
Facebook
Blockchain
Software
Medical
Web3
Theatre
Infrastructure
Recruiting
Crowdfunding
Celebrity
LGBT
Climate
Venture Capital
Cannabis
Wine and Spirits
Beauty
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Fashion
Music
Real Estate
Sporting Goods
Social
FinTech
Finance
Digital Media
Manufacturing
Social Media
Franchise
Financial Services
Non Profit
Internet
Android
Mobile Advertising
Sustainability
Proptech
Hardware
Enterprise
Impact
Transportation
Community
Biotech
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Guinea
Kyrgyzstan
Iran
Haiti
Lesotho
Isle of Man
Norway
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Oman
Romania
Puerto Rico
Poland
Armenia
Guernsey
Cameroon
Colombia
China
Costa Rica
Kuwait
Czech Republic
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Sierra Leone
Portugal
Philippines
El Salvador
Senegal
Germany
India
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Albania
Asia
Angola
Europe
Cyprus
Argentina
Bangladesh
Spain
Barbados
Belgium
Austria
Ethiopia
Jordan
Qatar
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bolivia
Belize
Algeria
Bahrain
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Bahamas
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Jersey
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical VC Funds & Investors in Switzerland (October 2026)

The most active venture capital funds investing in Switzerland Medical startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Switzerland Medical startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Zürcher Kantonal Bank
VC Fund
21 Switzerland, Germany, Japan Seed, Series A, Series B Health Care, Biotechnology, Medical Device $1M–$20M
Foundation for Innovation and Technology (FIT)
VC Fund
17 Switzerland, France, United States Debt Financing, Grant, Seed Health Care, Software, Artificial Intelligence $20k–$2.5M
Verve Ventures
VC Fund
12 Switzerland, Germany, France Seed, Series A, Series B Software, Health Care, Biotechnology $1.2M–$45M
SICTIC
VC Fund
9 Switzerland, Germany, Tanzania Seed, Venture - Series Unknown, Pre-Seed Software, Artificial Intelligence, Information Technology $264k–$11M
Bernina BioInvest
VC Fund
9 Switzerland Seed, Series A, Series B Biotechnology, Health Care, Medical $1.5M–$65M
Versant Ventures
VC Fund
8 United States, Switzerland, Canada Series A, Series B, Series C Biotechnology, Health Care, Medical $5M–$107M
Swisscom Ventures
VC Fund
6 Switzerland, United States, United Kingdom Series B, Series A, Series C Software, SaaS, Information Technology $2M–$80M
BlueOcean Ventures
VC Fund
6 Switzerland, India, France Seed, Series A, Series B Health Care, Medical, Personal Health $1M–$20M
StartAngels Network
VC Fund
6 Switzerland, Brazil Seed, Series A, Series B Health Care, Medical, Medical Device $933k–$5.7M
BioMedPartners
VC Fund
6 Switzerland, Germany, France Series A, Series B, Series C Biotechnology, Health Care, Medical $5.3M–$75M
Sofinnova Partners
VC Fund
5 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $7M–$105M
Kickfund
VC Fund
5 Switzerland, France, Germany Seed, Pre-Seed, Convertible Note Health Care, Biotechnology, Manufacturing $110k–$5.7M
4FOX Ventures
VC Fund
5 Switzerland, United States Series A, Seed, Series B Medical Device, Medical, Health Care $1.8M–$69M
Founderful
VC Fund
4 Switzerland, United Kingdom, Canada Pre-Seed, Seed, Series A Software, Artificial Intelligence, Information Technology $810k–$24M
Schroder Adveq
VC Fund
4 Switzerland, United States, India Series B, Series C, Series A Biotechnology, Health Care, Therapeutics $5M–$100M
Sunstone Life Science Ventures
VC Fund
4 Denmark, Sweden, Switzerland Series A, Series B Biotechnology, Health Care, Medical $5.5M–$61M
New Enterprise Associates
VC Fund
4 United States, China, India Series A, Series B, Series C Software, Health Care, Biotechnology $6M–$100M
OrbiMed
VC Fund
4 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Pharmaceutical $9M–$160M
Eclosion SA
VC Fund
4 Switzerland Seed, Series C Biotechnology, Pharmaceutical, Health Care $1.6M–$28M
M Ventures
VC Fund
4 United States, United Kingdom, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.4M–$100M
Zühlke Ventures AG
VC Fund
4 Switzerland, Sweden, United States Series A, Seed, Series B Health Care, Medical Device, Medical $1.1M–$11M
EIT Health
VC Fund
4 United Kingdom, Spain, Ireland Grant, Pre-Seed, Seed Health Care, Medical Device, Medical $27k–$1.7M
GoBeyond
VC Fund
4 Switzerland, Germany, United Kingdom Seed, Series A Information Technology, Medical, Software $544k–$10M
Fongit Seed Invest
VC Fund
4 Switzerland Seed, Series A, Series B Health Care, Medical, Biotechnology $1M–$3.3M
Broadview Ventures
VC Fund
4 United States, Switzerland, Canada Series A, Seed, Series B Health Care, Biotechnology, Medical Device $1M–$45M
VINCI CAPITAL
VC Fund
3 Switzerland, Germany Series A, Series B Medical, Health Care, Biotechnology $8.6M–$36M
Alpana Ventures
VC Fund
3 United States, Switzerland, Germany Seed, Series A Software, FinTech, Information Technology $850k–$14M
Gilde Healthcare
VC Fund
3 United States, The Netherlands, Germany Series B, Series C, Series A Health Care, Biotechnology, Medical $9.5M–$135M
Viva BioInnovator
VC Fund
3 United States, China, Canada Venture - Series Unknown, Seed, Series A Biotechnology, Health Care, Medical $1M–$20M
Polytech Ventures
VC Fund
3 Switzerland, United States, Spain Seed, Series A, Series B Software, Financial Services, FinTech $500k–$10M
XtalPi
VC Fund
3 China, United States, Japan Series A, Seed, Angel Biotechnology, Health Care, Pharmaceutical $1.5M–$50M
Endeavour Vision
VC Fund
3 United States, Switzerland, France Series C, Series B, Series A Health Care, Medical, Biotechnology $2.1M–$115M
4See Ventures
VC Fund
3 Switzerland, Israel Seed, Series A, Series C Medical, Health Care, SaaS $3.5M–$20M
Innosuisse
VC Fund
3 Switzerland, United States, United Kingdom Grant, Pre-Seed, Seed Health Care, Biotechnology, Medical Device $16k–$16M
EQT Life Sciences
VC Fund
3 United States, Switzerland, The Netherlands Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $7.3M–$165M
Index Ventures
VC Fund
3 United States, United Kingdom, France Series A, Series B, Seed Software, Artificial Intelligence, SaaS $1.4M–$102M
Accel
VC Fund
3 United States, India, United Kingdom Series A, Series B, Seed Software, Artificial Intelligence, SaaS $1.4M–$75M
Fuho Capital
VC Fund
3 China, Switzerland Series A, Angel, Series B Health Care, Biotechnology, Medical $425k–$44M
S2S Ventures
VC Fund
3 Switzerland, Germany Pre-Seed, Seed Health Care, Artificial Intelligence, Manufacturing $28k–$3.4M
Foundation for technological innovation
VC Fund
3 Switzerland Pre-Seed, Debt Financing Medical, Health Care, Medical Device $124k–$560k
Inserm Transfert Initiative
VC Fund
3 France, Switzerland, United States Series A, Series B, Seed Biotechnology, Medical, Health Care $1.1M–$60M
HTGF (High-Tech Gruenderfonds)
VC Fund
3 Germany, Switzerland, United States Seed, Series A, Pre-Seed Software, Biotechnology, Information Technology $790k–$31M
Yellowstone Holding
VC Fund
2 Switzerland, Taiwan, Germany Series A, Series B, Series C Medical, Health Care, Biotechnology
Grazia Equity
VC Fund
2 Germany, United States, Switzerland Series A, Series B, Seed Internet, E-Commerce, Biotechnology $1.1M–$59M
ORTHO INNOVATIONS
VC Fund
2 Switzerland Seed Medical, Health Care, Biotechnology
Healthspan Capital
VC Fund
2 Germany, Switzerland, United States Seed Health Care, Biotechnology, Medical
Reference Capital SA
VC Fund
2 United States, Switzerland, United Kingdom Series A, Series C, Series B Software, Health Care, Biotechnology
Calm/Storm Ventures
VC Fund
2 United Kingdom, Germany, Austria Seed, Pre-Seed, Series A Health Care, Wellness, Software
Novo Holdings
VC Fund
2 United States, Denmark, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $9M–$130M
Ecosystem Ventures
VC Fund
2 United States, India, Switzerland Seed, Series A, Angel Mobile Apps, Mobile, Finance $203k–$15M
Access all 541 VC funds in Switzerland Medical startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Zürcher Kantonal Bank
VC Fund · Zürich, Zurich, Switzerland · 21 investments in Switzerland Medical startups

Zürcher Kantonalbank is an independent, incorporated public-law institution is its public service mandate. Enshrined in law, it governs the bank's economic, social, and environmental commitment.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland, Germany, Japan

Investor stats

  • Total investments: 208
  • Round size: Seed $1M–$6M; Series A $2.1M–$13M; Series B $1.9M–$20M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: Likely actively investing — fresh fund, raised $150M in 2024

Portfolio highlights

  • Riverkin — Riverkin builds rugged, low-cost water sensor systems for rivers that measure turbidity and temperature in real time. Our platform turns field data into clear insights and decision making tools.
  • QualySense — QualySense is a Swiss start-up company focused on innovative high-throughput grain, beans and seeds sorting technology. QualySense develops a high-speed multi-tons per hour sorting device, which will change how grains, beans and seeds are processed and valued worldwide by assessing the biochemical quality of grains one by one. The QualySensesorters will enable customers to separate grain batches into different biochemical quality classes and sell the corresponding premium products at higher average prices. Food processors will be able to considerably increase the production value, and produce higher quality products in a non-interrupted process.
  • Pearltec AG — Headquartered in Schlieren / Zurich, Pearltec AG develops, produces and delivers solutions for the optimal storage, fixation and positioning of patients. Their products are based on unique, patented technology developed in collaboration with ETH Zurich and renowned university hospitals.They have set theirselves the goal to use the technologycompetence of Pearltec AG for the benefit of humans, animals and industry and to create added value for their customers by excellent quality and convincing application advantages.Pearltec AG is certified according to ISO standard 13485. This certification certifies that their quality management system for the development and manufacture of medical devices meets the highest international standards.
Show all investments...

Foundation for Innovation and Technology (FIT)
VC Fund · Lausanne, Vaud, Switzerland · 17 investments in Switzerland Medical startups, 24 in the past 12 months

The Foundation for Technology Innovation gives financial assistance to creative and technological projects at various phases of development. FIT funds projects in energy and the environment, information and digital technology, life sciences and health, precision industries, and nutrition and agriculture.

Show more...

Investment focus

  • Industry: Health Care, Software, Artificial Intelligence
  • Stage:Debt Financing, Grant, Seed
  • Geography: Switzerland, France, United States

Investor stats

  • Total investments: 275
  • Round size: Seed $100k–$2.5M; Grant $20k–$125k; Debt Financing $99k–$531k
  • Lead/follow: 93% lead, 7% follow

Portfolio highlights

  • SixtineAI — is an AI-driven clinical documentation and workflow assistant specifically designed for healthcare providers.
  • Nextrainers — Nextrainers is a sports technology company that provides AI-powered football training sessions, tactical analysis, and player progression.
  • Documenter AI — Complete AI copilot platform for enterprise project management, compliance automation, and business process automation. Deploy intelligent agents, automate workflows, and ensure compliance across all industries.
Show all investments...

Verve Ventures
VC Fund · Zug, Zug, Switzerland · 12 investments in Switzerland Medical startups, 9 in the past 12 months

Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland, Germany, France

Investor stats

  • Total investments: 305
  • Round size: Seed $1.2M–$12M; Series A $2.1M–$18M; Series B $3.9M–$45M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: Likely still investing — raised $61M in 2022

Portfolio highlights

  • Piomic — Non-invasive treatment with minimal staff supervision to produce a durable structural, functional and cosmetic closure of hard-to-heal wounds.
  • Aylight — Aylight develops semiconductor laser and photonics platforms designed to improve optical connectivity in AI datacenters and related infrastructure. The company focuses on frequency modulated comb laser technology that generates multiple stable wavelengths from a single InP-based laser cavity. Its architecture produces an equidistant, RF-lockedwavelength grid that aligns with dense wavelength-division multiplexing requirements and reduces control complexity and power consumption. Aylight targets use cases in AI datacenter interconnects, quantum computing hardware, precision metrology, and communication equipment. Its products aim to integrate with terabit optical links and wavelength-division multiplexing systems while remaining compatible with existing fabrication processes.
  • Undecimal Bio — Undecimal Bio operates as a platform biotechnology company that develops targeted delivery mechanisms for small interfering RNA (siRNA) therapeutics. The company utilizes a proprietary platform that combines combinatorial chemistry libraries with transformer-based artificial intelligence to discover molecular conjugates capable of guiding genetic medicines to specified cells outside of the liver. This approach aims to circumvent traditional delivery constraints to expand the reach of RNA therapeutics into a broader range of therapeutic areas and human organs.
Show all investments...

SICTIC
VC Fund · Zürich, Zurich, Switzerland · 9 investments in Switzerland Medical startups

SICTIC is the leading angel investor network in Switzerland with the largest Swiss seed-stage startup dealflow.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: Switzerland, Germany, Tanzania

Investor stats

  • Total investments: 301
  • Round size: Seed $504k–$3.7M; Pre-Seed $264k–$2.7M; Venture - Series Unknown $1.2M–$11M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • hypt — hypt is a Swiss based SaaS marketing solution that empowers companies to digitalize word-of-mouth. By using our word-of-mouth manager companies are able to activate 40% of their customers to send out a personal recommendation to their peers increasing sales through word-of-mouth by 4 times. Our solution empowers our ICP customers in the finance andinsurance segments to strategically use and optimize the most authentic and cost effective advertising channel – word-of-mouth – and makes it an accessible asset of every marketing mix.
  • Carewell — Carewell is influencing the way people work in healthcare by providing flexible digital solutions tailored to their specific needs.
  • Prevision Medicine — Prevision Medicine AG is a oncology company that provides cancer therapy, tests living cancer cells, and deliver clinical insights.
Show all investments...

Bernina BioInvest
VC Fund · Zug, Zug, Switzerland · 9 investments in Switzerland Medical startups

Bernina BioInvest is an investment Firm.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland

Investor stats

  • Total investments: 16
  • Round size: Seed $1.5M–$20M; Series A $15M–$65M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Versameb — Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNAmolecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
  • HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
  • Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
Show all investments...

Versant Ventures
VC Fund · Menlo Park, California, United States · 8 investments in Switzerland Medical startups

Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, Canada

Investor stats

  • Total investments: 333
  • Round size: Series A $5M–$78M; Series B $12M–$105M; Series C $12M–$107M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely still investing — raised $5M in 2024

Portfolio highlights

  • Inari Medical — Inari Medical is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. They are focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. It hasdeveloped two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.The company was founded in 2011 and is headquartered in Irvine, California.
  • Gate Bioscience — Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease.
  • Dayra Therapeutics — Dayra Therapeutics manufactures peptide based medicines.
Show all investments...

Swisscom Ventures
VC Fund · Zürich, Zurich, Switzerland · 6 investments in Switzerland Medical startups

Swisscom Ventures is an venture capital arm of Swisscom AG, that specializes in early stage tech investments founded in 2007. Swisscom Ventures invests in growth companies with emerging business models and technologies of strategic relevance to Swisscom's core business. As a value-add investor, Swisscom brings its investees the technical expertise and strategic insights of an incumbent telecom operator. We act as a bridge to Swisscom's operational business units, which portfolio companies can also leverage as a test environment for their products and services. Swisscom Ventures seeks minority stakes in companies related to the information/communications/entertainment space.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Series B, Series A, Series C
  • Geography: Switzerland, United States, United Kingdom

Investor stats

  • Total investments: 158
  • Round size: Series A $2M–$22M; Series B $2M–$60M; Series C $8.6M–$80M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely still investing — raised $300M in 2022

Portfolio highlights

  • Apono — Apono makes permission management to applications, infrastructure, and data repositories simple, secure and compliant.
  • CDDS — The CDDS interceptor is an autonomous, kinetic counter drone designed to neutralize Group 1 and Group 2 Unmanned Aerial System (UAS) threats with speed and precision.
  • Aylight — Aylight develops semiconductor laser and photonics platforms designed to improve optical connectivity in AI datacenters and related infrastructure. The company focuses on frequency modulated comb laser technology that generates multiple stable wavelengths from a single InP-based laser cavity. Its architecture produces an equidistant, RF-lockedwavelength grid that aligns with dense wavelength-division multiplexing requirements and reduces control complexity and power consumption. Aylight targets use cases in AI datacenter interconnects, quantum computing hardware, precision metrology, and communication equipment. Its products aim to integrate with terabit optical links and wavelength-division multiplexing systems while remaining compatible with existing fabrication processes.
Show all investments...

BlueOcean Ventures
VC Fund · Plan-les-ouates, Geneve, Switzerland · 6 investments in Switzerland Medical startups

BlueOcean Ventures SA provides capital, operational and company development advisory support (mentoring, company management, divestment experience, network, negotiation support) to entrepreneurs in Switzerland. BlueOcean Ventures is based in Geneva, Switzerland.

Show more...

Investment focus

  • Industry: Health Care, Medical, Personal Health
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland, India, France

Investor stats

  • Total investments: 17
  • Round size: Seed $1M–$3.1M; Series A $2.3M–$20M; Series B $4M–$16M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • UGX.ai — Connect, process, and optimise industrial operations across manufacturing, OEM, and clean energy with UGX.AI.
  • RockFlow — RockFlow is an investment wonderland for the young. Born to be brave, invest in the moment.
  • official.fm — Officials.fm has done an incredible job at creating a community that brings together different artists and listeners in a very creative and dynamic way.
Show all investments...

StartAngels Network
VC Fund · Zürich, Zurich, Switzerland · 6 investments in Switzerland Medical startups

StartAngels Network is a Zurich-based angel investment firm that provides investment consulting services.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland, Brazil

Investor stats

  • Total investments: 31
  • Round size: Seed $933k–$3.4M; Series A $2M–$3.5M; Series B $1.7M–$5.7M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Rflect — Rflect helps universities protect their business model in the age of AI by training the human skills machines cannot replace—reflection, resilience, collaboration—directly inside the curriculum for credit. As AI commoditizes knowledge and devalues degrees, Rflect secures degree value through measurable human development and audit-ready data foraccreditation, employability, and retention. Embedded as credit-bearing infrastructure, Rflect achieves 100% student usage, zero institutional churn, and long-term lock-in cycles.
  • Scanvio — Scanvio Medical provides gynecologists, endometriosis centers and ultrasound manufacturers with an AI-guided ultrasound software for faster endometriosis diagnosis.
  • Carewell — Carewell is influencing the way people work in healthcare by providing flexible digital solutions tailored to their specific needs.
Show all investments...

BioMedPartners
VC Fund · Basel, Basel-Stadt, Switzerland · 6 investments in Switzerland Medical startups

BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Switzerland, Germany, France

Investor stats

  • Total investments: 88
  • Round size: Series A $5.3M–$31M; Series B $5.3M–$75M; Series C $5.3M–$47M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: May invest from a new fund soon — raised $106M in 2018

Portfolio highlights

  • T-CURX — T-CURX develops a new generation of T cells for personalized cancer immunotherapy, built on a proprietary platform that overcome challenges ...
  • iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
  • ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 5 investments in Switzerland Medical startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 353
  • Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fresh fund, raised $755M in 2025

Portfolio highlights

  • Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
  • HighLife — HighLife is driven by a mission to deliver innovative treatment options to patients suffering from heart valve diseases.
  • EnginZyme — Enzymatic chemistry for cleaner ingredients in personal care, food and pharma. Enginzyme's patented EziG platform makes enzymes work at industrial scale.
Show all investments...

Kickfund
VC Fund · Basel, Basel-Stadt, Switzerland · 5 investments in Switzerland Medical startups, 13 in the past 12 months

Kickfund is a Venture Capital fund that systematically backs companies that successfully complete Venture Kick.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: Switzerland, France, Germany

Investor stats

  • Total investments: 51
  • Round size: Seed $1.1M–$5.7M; Pre-Seed $335k–$4M; Convertible Note $110k–$118k
  • Lead/follow: 16% lead, 84% follow
  • Last fund: Likely still investing — raised $80M in 2023

Portfolio highlights

  • Bewelab SA — Bewe is a mobile game designed to reduce cravings, using neuroscience to automatically retrain your brain and effortlessly reclaim your health.
  • Immitra Bio — Developing scalable in-vivo genomic medicine for blood disorders
  • Helix Robotics — We are building the first commercial soft manipulator
Show all investments...

4FOX Ventures
VC Fund · Luxembourg, Luxembourg, Luxembourg · 5 investments in Switzerland Medical startups

4FO Ventures

Show more...

Investment focus

  • Industry: Medical Device, Medical, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: Switzerland, United States

Investor stats

  • Total investments: 23
  • Round size: Seed $1.8M–$3.3M; Series A $1.8M–$11M; Series B $5.5M–$69M
  • Lead/follow: 52% lead, 48% follow

Portfolio highlights

  • Positrigo — NeuroLF is an ultra-compact brain Positron Emission Tomography system. Our technology makes functional imaging accessible for people worldwide.
  • Ecorobotix — Discover how Ecorobotix is revolutionizing precision agriculture with AI-driven field sprayers. Cut costs, boost yields, and farm smarter with precision ag technology.
  • Neo Medical — Neo aims at transforming the current approach to spinal surgery by providing a unique answer to the worldwide strive for healthcare cost optimization through efficient, versatile and high quality systems.
Show all investments...

Founderful
VC Fund · Zürich, Zurich, Switzerland · 4 investments in Switzerland Medical startups, 12 in the past 12 months

Founderful is Switzerland’s leading pre-seed fund. Founderful is the first, fast, and founder-friendly, backing Switzerland's best tech entrepreneurs to become global market leaders. Founded in 2019 and is located in Zurich, Zurich.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Switzerland, United Kingdom, Canada

Investor stats

  • Total investments: 112
  • Round size: Seed $1.5M–$14M; Pre-Seed $810k–$4.3M; Series A $3M–$24M
  • Lead/follow: 55% lead, 45% follow
  • Last fund: Likely still investing — raised $143M in 2024

Portfolio highlights

  • UniSieve — UniSieve is a cleantech company that provides molecular separation membrane solutions for a wide range of applications. Its platform technology enables a unique combination of various molecular sieves and polymeric membranes, yielding reliable separation solutions. The company was founded in 2018 and is headquartered in Zurich, Switzerland.
  • Fusionality — Fusionality is a Swiss fusion-technology company focused on measurement, control, and data systems for fusion devices.They combine expertise in fusion physics, control engineering, AI/ML, simulation, diagnostics, and real-time software.Their goal is to help fusion companies and research labs operate devices more efficiently and accelerate thedevelopment of commercial fusion energy.
  • Exclaim Robotics — Autonomous mobile robots for the AI data center.
Show all investments...

Schroder Adveq
VC Fund · Zürich, Zurich, Switzerland · 4 investments in Switzerland Medical startups

Schroders Capital provides investors with access to a broad range of private asset investment opportunities, portfolio building blocks and customised private asset strategies. With over $65 billion assets under management, we offer a diversified range of investment strategies, including real estate, private equity, secondaries, venture capital, infrastructure, securitised products and asset-based finance, insurance-linked securities and impact investing.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series C, Series A
  • Geography: Switzerland, United States, India

Investor stats

  • Total investments: 36
  • Round size: Series A $5M–$22M; Series B $11M–$73M; Series C $15M–$100M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: May invest from a new fund soon — raised $113M in 2020

Portfolio highlights

  • Bizongo — Bizongo is a Tech-Enabled B2B Platform for Packaging, Apparels & Other Customised Goods. We digitally transform vendor management & supply chain.
  • Lenskart — Lenskart, the first of its kind online optical store in India, has made it possible to acquire a good quality pair of specs with prescription lenses for just Rs. 399. With a 48-hour free home delivery guarantee and 365 days return policy, Lenskart.com is doing what e-commerce hasn’t been able to do in India yet. The website has over 500 designs of eye frames, in multiple colors, for all age groups, from Rs. 399 all the way to Rs. 4,000 for a pair. All one needs to do is select a frame, fill in their power, and place an order. You can pay online or at the time of delivery. Lenskart.com has the biggest collection of discounted contact lenses consisting of all top-notch brands (viz. Johnson & Johnson, Bausch & Lomb, Ciba Vision to name a few) and be it disposable, toric, colored, or bifocal contact lenses, you can find all possible types here. Lenskart is dedicated to providing its customers with a simple, hassle-free way to replace their contact lenses. One can receive the exact same contact lens, their doctor prescribed, delivered to their door, at a great price.
  • Memo Therapeutics — Memo Therapeutics AG translate immune responses into superior medicines. Our best-in-class antibodies transform lives of patients with viral infections & cancer
Show all investments...

Sunstone Life Science Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 4 investments in Switzerland Medical startups

Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: Denmark, Sweden, Switzerland

Investor stats

  • Total investments: 63
  • Round size: Series A $5.5M–$61M; Series B $9.5M–$58M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: May invest from a new fund soon — raised $92M in 2019

Portfolio highlights

  • Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
  • Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show all investments...

New Enterprise Associates
VC Fund · Menlo Park, California, United States · 4 investments in Switzerland Medical startups

Foundational partners to ambitious founders at every stage of company-building.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: United States, China, India

Investor stats

  • Total investments: 2101
  • Round size: Series A $6M–$55M; Series B $10M–$85M; Series C $15M–$100M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — raised $468M in 2024

Portfolio highlights

  • Zyngenia —
  • Alteon Websystems — Alteon Websystems is a computer network hardware company that provides internet infrastructure solutions enabling e-businesses to meet their increasing demands.  The company’s portfolio of web data center products includes switches, server adapters, and software that are optimized to meet the specific challenges of managing web application trafficand provide high performance network infrastructure solutions.Alteo Websystems was founded in 1996 and is headquartered in San Jose, California.
  • Lithium Technologies — Lithium builds trusted relationships between the world’s best brands and their customers, helping people get answers and share their experiences. Brands like Microsoft, HP, Sephora, Virgin and Barclaycard and customers in more than 34 countries rely on Lithium to help them connect, engage, and understand their total community. With more than 100million monthly visits over all Lithium communities and 750 million online profiles scored by Klout, Lithium has one of the largest digital footprints in the world. Using that data and the company’s software, Lithium customers boost sales, reduce service costs, spark innovation, and build long-term brand loyalty and advocacy.
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 4 investments in Switzerland Medical startups

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 767
  • Round size: Series A $9M–$116M; Series B $23M–$148M; Series C $19M–$160M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fresh fund, raised $192M in 2026

Portfolio highlights

  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
  • InventisBio — InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company isco-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.
  • Bonovo Orthopedics —
Show all investments...

Eclosion SA
VC Fund · Geneva, Geneve, Switzerland · 4 investments in Switzerland Medical startups

Eclosion assists entrepreneurs with the necessary resources to bridge the gap between their laboratories and the stage where the start-up can reasonably attract risk capital. Eclosion helps you to cross the bridge to convert your innovation into a realistic venture and to enter into its growth phase.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Seed, Series C
  • Geography: Switzerland

Investor stats

  • Total investments: 16
  • Round size: Seed $1.6M–$2.7M; Series C $20M–$28M
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • KYLYS — KYLYS is an innovative Swiss company based in Geneva founded in March 2017. KYLYS provides people and patients with highly effective and safe products based on biomolecules.
  • Genkyotex — Genkyotex is dedicated to the development of innovative drugs which block enzymes that produce oxygen radicals. Such novel drugs will allow the treatment of oxygen-radical mediated acute and chronic diseases, with improved specificity, safety, and efficacy over existing antioxidants therapy, giving them a significant competitive advantage.Genkyotex targets its technology initially to the therapeutic areas of cardiovascular, metabolic and neurodegenerative diseases.
  • MPC Therapeutics — MPC Therapeutics develops a novel class of compounds with application in Immunotherapy and Metabolic diseases
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 4 investments in Switzerland Medical startups

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 189
  • Round size: Seed $2.4M–$24M; Series A $5.8M–$56M; Series B $13M–$100M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Mueon — semiconductor-based systems for AI and hyperscale computing
  • iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
  • Polaris Electro-Optics — Polaris Electro-Optics empowers integrated photonics for communications and computation.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Zühlke Ventures AG
VC Fund · Schlieren, Zurich, Switzerland · 4 investments in Switzerland Medical startups

Zühlke Ventures AG is a venture capital arm of Zühlke Technology Group AG specializing in financing of start-ups at an early stage and providing growth capital. It seeks to invest in the technology and medical devices companies. It typically invests in German-speaking Europe and Great Britain.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series A, Seed, Series B
  • Geography: Switzerland, Sweden, United States

Investor stats

  • Total investments: 15
  • Round size: Seed $1.1M–$3M; Series A $7M–$11M
  • Lead/follow: 47% lead, 53% follow

Portfolio highlights

  • Bottneuro — Bottneuro strives to set new standards in personalized neuromodulation - achieving better results and improving quality of life. Find out more!
  • Indivi — Healios CTMS provides the Digital Biomarker based technology and digital validation scales to improve and streamline research and clinical practice.
  • PeriVision — At Perivision, we combine artificial intelligence (AI), virtual reality (VR) and the cloud to build the next generation systems to understand visual function. Our systems improve workflow efficiency in practices and hospitals and provide deeper clinical insight into eye diseases.
Show all investments...

EIT Health
VC Fund · Munich, Bayern, Germany · 4 investments in Switzerland Medical startups

EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Grant, Pre-Seed, Seed
  • Geography: United Kingdom, Spain, Ireland

Investor stats

  • Total investments: 106
  • Round size: Seed $220k–$1.4M; Grant $27k–$1.6M; Pre-Seed $45k–$1.7M
  • Lead/follow: 59% lead, 41% follow

Portfolio highlights

  • IDOVEN — Idoven has developed the world’s first AI cardiologist -Willem- that augments both a cardiologist’s and non-cardiology expert clinician’s ability to identify, triage and diagnose patients at scale through APIs. The company counts clients such as AstraZeneca, Abbott, Novartis, GE Healthcare, FIFPRO, Google, Santander and Real Madrid Foundation.Idoven is backed by top-tier investors and business angels including Insight Partners, Northzone and Wayra (Telefónica), Iker Casillas, Pau Gasol, the Accel Starters program, EIC Accelerator, Horizon 2020, ERC and EIT Health. The company has been awarded with numerous distinctions for its AI technology in Europe and the US, including the the European Seal of Excellence 3x from the European Commission, granted by Horizon 2020, European Research Council ERC 2x (RIA) Europe’s most prestigious research grant, supporting excellent researchers in carrying out ground-breaking, high-risk, high-gain, frontier research projects, EIC Accelerator, and EIT Health. Idoven was ranked #1 Spanish HealthTech company in 2020 by NEOTEC. Idoven has been Google for Startups Resident at Google Campus Madrid and part of the Google for Startups Global Alumni Program. The company has won the prize Emprendedor XXI from CaixaBank, the Healthy Longevity Catalyst Award from the U.S. National Academy of Medicine, and has been awarded at South Summit 2021 as the Most Disruptive Startup, and Best Health and Wellbeing Startup. Selected by CB Insights as one of the top 150 global companies in Digital Health for 2022, and top 50 global companies in Digital Health for 2023. Idoven was recognized by TIME Magazine as one of the World's Top HealthTech Companies of 2025.
  • Noah Labs — A breakthrough for heart failure: Noah Labs Ark is a Class IIa Medical Device Software with AI-driven detection of early cardiac decompensation through voice.
  • Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
Show all investments...

GoBeyond
VC Fund · Zürich, Zurich, Switzerland · 4 investments in Switzerland Medical startups

GoBeyond is a FinTech company transforming angel investing into a new scalable asset class for small and large, novice to experienced investors. It offers a unique deal platform, portfolio tools, syndication/pooling, due diligence, investment monitoring services, training and certified deal leaders.Its clients are individuals, familyoffices, professional groups and corporations. It is active in the EU, Switzerland and the US. GoBeyond also offers educational training modules for angel investors in 11 categories.

Show more...

Investment focus

  • Industry: Information Technology, Medical, Software
  • Stage:Seed, Series A
  • Geography: Switzerland, Germany, United Kingdom

Investor stats

  • Total investments: 163
  • Round size: Seed $544k–$5M; Series A $1.2M–$10M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Fastree3D — Fastree3D imaging sensors help recognize and measure distance to fast moving objects in real-time, enabling driving assistance or autonomous navigation. Fastree3D SA is a fabless semiconductor company, spin-off from EPFL Lausanne, Switzerland founded in September 2013 (UID CHE-291.330.490). The company subsidiary Fastree3D B.V. performs researchwith TU-Delft, Netherlands (KvK 58866973).
  • Spyra One — Single Shot Technology | Tactical display | Automatic Refill | Power Shot SpyraTwo - the world's strongest water gun! Start epic water battles with the only water gun in the world that features our patented Single-Shot-Technology, fully automatical pump, a hightech tactical display and the Power Shot for extra impact.
  • DomoHealth — Join us in revolutionizing patient care using the power of AI-assisted digital health platform and safety solutions. Enhancing digital health with the best platform, application and devices for the direct benefits of patients and healthcare professionals.
Show all investments...

Fongit Seed Invest
VC Fund · Plan-les-ouates, Geneve, Switzerland · 4 investments in Switzerland Medical startups

Fongit Seed Invest (FSI) is the leading Seed Money Fund of Switzerland for young technology companies. It provides smart seed capital.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland

Investor stats

  • Total investments: 9
  • Round size: Seed $1M–$1.4M; Series A $2.3M–$3.3M
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • EBAMed — EBAMed builds CardioKit: live ultrasound that follows the heart during radiotherapy and gates the beam, whether the heart is the target or the organ to protect.
  • Gmelius — Gmelius is the world's first 360 email collaboration platform designed for Gmail and your company's daily apps. Join the async movement!
  • Annaida Technologies — Empowering fertility providers and researchers with AI-driven metabolomic platforms. Non-invasive, real-time insights at the microscale for personalized medical treatments.
Show all investments...

Broadview Ventures
VC Fund · Boston, Massachusetts, United States · 4 investments in Switzerland Medical startups

Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures. The Foundation Leducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support. With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Seed, Series B
  • Geography: United States, Switzerland, Canada

Investor stats

  • Total investments: 85
  • Round size: Seed $1M–$18M; Series A $1M–$20M; Series B $2.5M–$45M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Adient Medical — Medical Devices that Automatically Vanish - Adient Medical is leading the development of an absorbable vascular filter for the prevention of pulmonary embolism.
  • HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
  • Viridian Therapeutics (Formerly MiRagen Therapeutics) — Committed to developing potential best-in-class medicines for people affected by Thyroid Eye Disease and other autoimmune and rare diseases.
Show all investments...

VINCI CAPITAL
VC Fund · Lausanne, Vaud, Switzerland · 3 investments in Switzerland Medical startups

Vinci Capital is a leading Swiss private equity firm with over MCHF 200 under management. Since 1998 they have provided equity to over 30 Swiss technology and industrial companies to finance innovation, growth and succession-buyouts. Their investment team capitalizes on 40 years of cumulated experience in private equity and a solid operational background in growth, turn-around, consolidation, IPOs and M&A situations.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Series B
  • Geography: Switzerland, Germany

Investor stats

  • Total investments: 15
  • Round size: Series A $8.6M–$20M; Series B $21M–$36M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $10M in 2012

Portfolio highlights

  • Anergis — Anergis, a clinical-stage biopharmaceutical company, discovers and develops allergy vaccines based on the technology of Contiguous Overlapping Peptides for ultra-fast desensitization. It offers vaccines against birch pollen, ragweed pollen, and house dust mite allergies. Francois Spertini founded Anergis in 2001. Its headquarters in Lausanne inSwitzerland.
  • SENSIMED — Sensimed designs, develops, and commercializes integrated micro-systems for medical devices. The company’s product portfolio includes SENSIMED Triggerfish, a product that offers an automated recoding of continuous ocular dimensional change over 24 hours. Sensimed is now focused on expanding the knowledge of how this individual data can best beused in the clinical setting to deliver customized treatment. The 24 hour profiles are being centralized on a registry together with patient and treatment information. The data is being analyzed and modeled on an ongoing basis in an attempt to identifying pathological patterns that can be used to differentiate indication, personalize treatment and assess efficacy following treatment.Sensimed was founded by Matteo Leonardi and Sacha Cerboni in August 2003 and is based in Lausanne, Switzerland.
  • beqom — beqom is a Total Compensation Management Software Solution focused exclusively on managing compensation & performance for HR & Sales.
Show all investments...

Alpana Ventures
VC Fund · Geneva, Geneve, Switzerland · 3 investments in Switzerland Medical startups

Alpana Ventures is a Swiss VC focusing on digital transformation.Since 2016 we backed 45 founder teams with 3 Funds, supporting them in their journey towards a positive impact.Committed to value creation, we discover deep tech solutions in Switzerland, Europe and the US.We invest to embed them into innovative business models and back them tobecome global market leaders.Applying ESG criteria, our portfolio companies help create a more sustainable future.

Show more...

Investment focus

  • Industry: Software, FinTech, Information Technology
  • Stage:Seed, Series A
  • Geography: United States, Switzerland, Germany

Investor stats

  • Total investments: 98
  • Round size: Seed $850k–$4M; Series A $2.3M–$14M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
  • Nezasa — Discover how to grow your business with Nezasa TripBuilder, the world's leading travel commerce solution for travel businesses.
  • Tinamu — Trusted inventory intelligence delivered in real-time
Show all investments...

Gilde Healthcare
VC Fund · Utrecht, Utrecht, The Netherlands · 3 investments in Switzerland Medical startups, 6 in the past 12 months

Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series C, Series A
  • Geography: United States, The Netherlands, Germany

Investor stats

  • Total investments: 131
  • Round size: Series A $9.5M–$62M; Series B $14M–$135M; Series C $21M–$80M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely actively investing — fresh fund, raised $296M in 2026

Portfolio highlights

  • Big Health — Our mission is to help millions back to good mental health. Our digital therapeutics are safe and effective non-drug alternatives for mental health.
  • GT Medical Technologies — GT Medical Technologies is a medical technology company focused on improving outcomes for patients with brain tumors through treatment solutions. It was established by to address unmet needs in neuro-oncology and advance the standard of care for patients with operable brain tumors. The company's flagship product, GammaTile®, is an FDA-cleared,bioabsorbable collagen implant embedded with radiation seeds that delivers targeted radiation therapy directly to the surgical cavity immediately following tumor removal. By providing localized treatment at the time of surgery, GammaTile is designed to target residual cancer cells while reducing radiation exposure to surrounding healthy brain tissue. This approach aims to help prevent tumor recurrence and improve patient outcomes.
  • Endovascular Engineering — Endovascular Engineering is a medical technology company focused on developing and deploying advanced clot removal solutions for the treatment of venous thromboembolism. It specializes in thrombectomy technologies designed to improve clinical outcomes and procedural efficiency in minimally invasive vascular interventions. The company’s flagshipinnovation is the Hēlo™ Thrombectomy System, a catheter-based device that uses a combination of mechanical agitation and physician-controlled aspiration to remove blood clots. Its technology emphasizes features such as a self-expanding funnel design and dual-action functionality to enhance clot engagement and navigation through complex anatomies. Endovascular Engineering primarily serves healthcare providers, including interventional cardiologists and radiologists, supporting the treatment of conditions such as pulmonary embolism and deep vein thrombosis.
Show all investments...

Viva BioInnovator
VC Fund · Shanghai, Shanghai, China · 3 investments in Switzerland Medical startups

Viva BioInnovator (VBI) is the specialized investment and incubation arm of Viva Biotech Holdings. We focus on the initial creation and development of biotech startups across all indications and drug types. During the early stages of drug discovery, we can nurture and accelerate a startup's growth from idea to clinical program. VBI'sunique investment and incubation model started out of necessity in 2014. Our roots are in drug discovery services, where we operate world-leading and proprietary drug discovery platforms. While serving big pharma customers from around the globe, we came to realize the huge demand from many entrepreneurs who have great ideas but cannot receive funding to advance their plan due to lack of data. We saw the value in many of these innovative ideas and provided our CRO drug discovery services, operational support, and monetary backing to help these creative scientists embark on the "0 to 1"​ transformation. This spark launched our "equity for service (EFS)"​ investment and incubation model. VBI is based in Shanghai, with an office in Boston and personnel in California. As of early 2019, VBI has invested in over 30 companies out of the hundreds of proposals submitted for review and we plan to invest at a rapid pace in the years to come. The majority of our current portfolio companies are US based, but we are open to proposals globally and are excited to see new ideas that fit our investment strategy. If you would like to learn more about us, please visit: www.vivabioinnovator.com Or send an email to innovation@vivabiotech.com If you would like to learn more about our parent company, Viva Biotech, please visit: www.vivabiotech.com

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Venture - Series Unknown, Seed, Series A
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 65
  • Round size: Seed $1M–$20M; Series A $3M–$20M; Venture - Series Unknown $3.2M–$8.6M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
  • Vincere Biosciences — Vincere Biosciences is a JLABS incubator company whose mission is to develop drugs to halt the progression of Parkinson's disease (PD).
  • Proviva Therapeutics, Inc — Prodrug design platform for cytokines and other fusion proteins
Show all investments...

Polytech Ventures
VC Fund · Lausanne, Vaud, Switzerland · 3 investments in Switzerland Medical startups

Polytech Ventures are an early stage VC firm based in Switzerland with a strong international focus. Their strategic location at EPFL in Lausanne grants us access to one of the most dynamic and recognized innovation centers in the world

Show more...

Investment focus

  • Industry: Software, Financial Services, FinTech
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland, United States, Spain

Investor stats

  • Total investments: 53
  • Round size: Seed $500k–$3.5M; Series A $2.1M–$10M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2016

Portfolio highlights

  • Relai — All you need to get started is to download our award winning Relai app, complete a simple verification and start buying with as little as 50 CHF/EUR.
  • Hemostod — Developing universal platelets and next-generation diagnostics
  • Earny — Payroll management built for Startups & SMEs. Swiss payroll service with no hidden fees & no hassle
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
XtalPi
VC Fund · Cambridge, Massachusetts, United States · 3 investments in Switzerland Medical startups, 8 in the past 12 months

XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enables pharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide. Founded in 2014 by a group of quantum physicists at MIT, XtalPi has since grown into an elite team of researchers with multi-disciplinary expertise in physics, chemistry, pharmaceutical R&D, and algorithm design. XtalPi has received much recognition for its cutting-edge technologies, its innovative solutions, and the breadth of potential applications of its offerings across the pharmaceutical value chain, which has allowed it to gain industry approval and establish strategic partnerships with several top international pharmaceutical companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Seed, Angel
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 28
  • Round size: Seed $1.5M–$15M; Angel $9.2M–$50M; Series A $11M–$30M
  • Lead/follow: 43% lead, 57% follow

Portfolio highlights

  • Rabbitpre — Rabbitpre is a big data-driven technology marketing company.
  • Xellar Biosystems — Xellar's HTS Organ-on-Chip platform uses microfluidics and AI to deliver 90% predictive accuracy in preclinical drug discovery.
  • Apex Intelligence — Apex Intelligence is an artificial intelligence research laboratory that develops self-evolving foundation models designed to autonomously advance open-ended scientific discovery.
Show all investments...

Endeavour Vision
VC Fund · Geneva, Geneve, Switzerland · 3 investments in Switzerland Medical startups

Endeavour Vision is an investment advisory firm focused on transformative healthcare technologies.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series C, Series B, Series A
  • Geography: United States, Switzerland, France

Investor stats

  • Total investments: 77
  • Round size: Series A $2.1M–$30M; Series B $7M–$48M; Series C $12M–$115M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $375M in 2021

Portfolio highlights

  • Nalu Medical — Nalu Medical is an early-stage company that develops a range of medical devices. Their vision to modernize and improve the technology in medical devices, thus improving the lives of people.The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS)and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The company was founded in 2014 and is based in Carlsbad, California.
  • Venture Med Group — VentureMed Group (VMG) designs, develops and markets innovative medical devices which enable interventionalists to cost effectively treat peripheral artery diseases and improve the lives of their patients.Founded by physicians who understand the clinical, medical and financial demands in today’s healthcare environment, VMG creates truly costeffective solutions. Their flagship product, the FLEX Scoring Catheter enables providers to reduce expensive inventory costs while offering the interventionalist more treatment options from a single device.
  • Kestra Medical Technologies, Inc. — Kestra Medical Technologies is a wearable medical device and digital healthcare company that protects patients with diagnostic and therapeutic technologies that are intuitive, and mobile. They provide intuitive medical technologies to protect and support at-risk patients.
Show all investments...

4See Ventures
VC Fund · Secheron, Geneve, Switzerland · 3 investments in Switzerland Medical startups

4see ventures is a Swiss venture capital firm investing in exceptional entrepreneurs who are defining the future. We focus on real game-changers in their industries who are having a positive impact on society.

Show more...

Investment focus

  • Industry: Medical, Health Care, SaaS
  • Stage:Seed, Series A, Series C
  • Geography: Switzerland, Israel

Investor stats

  • Total investments: 7
  • Round size: Seed $3.5M–$20M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • FenX — FenX is a recyclable insulating product that turns mineral waste into usable resources to support a circular economy. Real estate developers, construction companies, and architects can now access non-flammable insulation materials for construction processes. the company's portfolio of recyclable insulation materials, which includes foamproducts and foam formulations made from readily available waste or natural materials with CO2 emissions.
  • PowerAPI — Foodetective enables F&B businesses to integrate & manage their entire tech stack from a single OS & platform. Increasing online revenues and visibility as well as removing all operational & administrative tasks. Our vision is to become the intelligent OS & interface of the F&B industry.
  • HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
Show all investments...

Innosuisse
VC Fund · Berne, Bern, Switzerland · 3 investments in Switzerland Medical startups, 10 in the past 12 months

Innosuisse’s role is to promote science-based innovation in the interests of industry and society in Switzerland.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Grant, Pre-Seed, Seed
  • Geography: Switzerland, United States, United Kingdom

Investor stats

  • Total investments: 236
  • Round size: Seed $500k–$16M; Grant $41k–$2.5M; Pre-Seed $16k–$4.3M
  • Lead/follow: 79% lead, 21% follow

Portfolio highlights

  • Actival — Actival is driven by innovation and the integration of AI tools in dentistry. It is committed to precision and oral health.
  • Precise Health — Why replace antibiotics when we can make them work better? AI reads the bacterial genome, matches the adjunct. Phages first.
  • BLEEDnFIRE Therapeutics — BLEEDnFIRE Therapeutics: At BLEEDnFIRE Therapeutics, we are pioneering innovative siRNA-based therapies for hemophilia, Von Willebrand disease & other rare bleeding disorders (RBDs) by developing BnF-001. Our mission is to transform patient care and improve quand improve quality of life through targeted ...
Show all investments...

EQT Life Sciences
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 3 investments in Switzerland Medical startups

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, The Netherlands

Investor stats

  • Total investments: 189
  • Round size: Series A $7.3M–$78M; Series B $11M–$114M; Series C $12M–$165M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $282M in 2023

Portfolio highlights

  • Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
  • ActoGeniX — ActoGeniX is a biopharmaceutical company focused on the development and commercialization of a range of biological drugs. ActoGeniX was founded by Bernard Coulie and Mark Vaeck in 2006 and is based in Zwijnaarde, Belgium.
  • Vaderis Therapeutics — Vaderis Therapeutics is a biotechnology company in the clinical stages that specializes in the treatment of uncommon and orphan diseases.
Show all investments...

Index Ventures
VC Fund · San Francisco, California, United States · 3 investments in Switzerland Medical startups

Index Ventures is an international venture capital firm with dual headquarters in San Francisco and London, investing in technology-enabled companies with a focus on e-commerce, fintech, mobility, gaming, infrastructure/AI, and security.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 1591
  • Round size: Seed $1.4M–$16M; Series A $5M–$35M; Series B $12M–$102M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely actively investing — fresh fund, raised $400M in 2026

Portfolio highlights

  • Moleskine — Moleskine develops, distributes, and sells notebooks, diaries, portfolios, purses, writing materials, reading articles, and many other products in Italy and internationally.The company offers paper products such as notebooks, diaries, home and office products, and gifts as well as writing, travelling, and reading collections, including pens,pencils, bags, reading glasses, and book lights. It also offers digital services and products comprising templates and applications for smartphones and tablets; Smart Notebook; and print-on-demand services for the creation of photo-books.Moleskine distributes its products in approximately 105 countries through a network of book, department, specialty, and stationery stores as well as museums; its sales network and websites; and a retail network of 30 directly-operated stores, including 9 in China, 12 in Italy, 2 in the United Kingdom, 2 in France, and 5 in the United States.Moleskine was founded in 1997 and is based in Milan, Italy.
  • PanGenetics — PanGenetics B.V. develops monoclonal antibodies for the treatment of immune mediated diseases.PanGenetics is a clinical development company that specializes in taking antibodies from the late research stage through to clinical proof of concept. The company is based in Utrecht, the Netherlands with an office in Cambridge, UK. PanGenetics employsa lean business model with manufacturing and clinical development activities outsourced to specialist providers. Apart from PG110, the other clinical program of PanGenetics is PG102, a CD40 antagonist for treatment of autoimmune diseases which is currently being evaluated in a clinical study in psoriatic arthritis patients
  • Milestone Systems — See and know more with video technology. Milestone offers award-winning XProtect video management software, Arcules VSaaS, and BriefCam analytics.
Show all investments...

Accel
VC Fund · Palo Alto, California, United States · 3 investments in Switzerland Medical startups

First partner to exceptional teams everywhere

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Series A, Series B, Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 2506
  • Round size: Seed $1.4M–$10M; Series A $4.3M–$40M; Series B $9.5M–$75M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: Likely actively investing — fresh fund, raised $750M in 2026

Portfolio highlights

  • Discord — Discord is the easiest way to talk over voice, video, and text. Talk, chat, hang out, and stay close with your friends and communities.
  • Vectra AI — Vectra AI delivers AI-native security and observability across network, identity, cloud, SaaS, and AI environments to reduce exposure, accelerate response, and strengthen cyber resilience.
  • Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Show all investments...

Fuho Capital
VC Fund · Haidian, Beijing, China · 3 investments in Switzerland Medical startups

Fuho Capital is an equity investment fund management company.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Angel, Series B
  • Geography: China, Switzerland

Investor stats

  • Total investments: 32
  • Round size: Angel $425k–$3.2M; Series A $709k–$15M; Series B $2.8M–$44M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Novamab — Novamab focuses on the research and development of new nanobodies. The core members of the team have 15 years of experience in nanobody research and development, and are domestic nanobody "pioneers". At present, they have established an inhaled macromolecular drug research and development platform, an albumin nanobody long-acting platformand a nanobody double-antibody platform, etc., to give full play to nanobody The advantages of antibodies, the development of innovative nanobody drugs such as sprays and eye drops, to solve the pain points of clinical major chronic diseases in terms of administration methods, administration cycles, etc.
  • Leman Biotech — Leman Biotech is a biotech company that is engaged in development of cancer immunotherapies.
  • Hexaell Biotech — Hexaell Biotechnology Co., Ltd is a start-up company pioneering in stem cell and artificial organ. The disruptive technologies were original published in "Nature. 475(7356):386-9" and "Cell Stem Cell. 14(3):370-84" from Chinese Academy of Sciences. Hexaell Biotechnology had licensed iHep and HiHep technologies from ChineseAcademy of Sciences and developed medical devices of bio-artificial liver to replace liver function of human and cure liver failure diseases. Hexaell has finished pilot clinical studies in 6 liver failure patients in leading hepatopathy centers in China.
Show all investments...

S2S Ventures
VC Fund · Zürich, Zurich, Switzerland · 3 investments in Switzerland Medical startups

S2S Ventures is a fully student-led VC fund from Switzerland, backed by some of the country's most successful entrepreneurs.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Manufacturing
  • Stage:Pre-Seed, Seed
  • Geography: Switzerland, Germany

Investor stats

  • Total investments: 28
  • Round size: Seed $954k–$3.4M; Pre-Seed $28k–$2.7M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: Likely still investing — raised $11M in 2021

Portfolio highlights

  • Haicker — Continuous, automated vulnerability scanning for your web codebases. Cheaper, faster, and more efficient than traditional pentesters.
  • Scanvio — Scanvio Medical provides gynecologists, endometriosis centers and ultrasound manufacturers with an AI-guided ultrasound software for faster endometriosis diagnosis.
  • Forgis — Forgis is leading the next industrial revolution by introducing industrial intelligence into factories, which boosts the competitiveness of Western manufacturing.
Show all investments...

Foundation for technological innovation
VC Fund · 3 investments in Switzerland Medical startups

Foundation for technological innovation provides support for start-up founders with projects based in the business and residential area.

Show more...

Investment focus

  • Industry: Medical, Health Care, Medical Device
  • Stage:Pre-Seed, Debt Financing
  • Geography: Switzerland

Investor stats

  • Total investments: 4
  • Round size: Pre-Seed $284k–$560k; Debt Financing $124k–$124k
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Gaia Tech — Gaia Technologies turns agricultural sidestreams into high-value ingredients for cosmetics, food, and feed manufacturers.
  • Precisia Care — Precisia Care is a company that uses real-time clinical data obtained directly from hospital operations to make actionable AI-driven forecasts and recommendations.
  • Dexterous Endoscopes — Experience variable stiffness endoscopes that adapt to your needs, delivering precision, control, and better outcomes for every patient.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Inserm Transfert Initiative
VC Fund · Paris, Ile-de-France, France · 3 investments in Switzerland Medical startups

Inserm Transfert Initiative is a seed stage life science vehicle currently managing about €4.2M for the financing of new biotech companies. Inserm Transfert Initiative is the new investment vehicle of INSERM in France.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: France, Switzerland, United States

Investor stats

  • Total investments: 23
  • Round size: Seed $2.7M–$3.6M; Series A $1.1M–$35M; Series B $2.2M–$60M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Eyevensys — Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasiveprocedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability.They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.
  • VectivBio — Explore Ironwood Pharmaceuticals' commitment to GI health with innovative therapies, patient-focused research, and a vision to improve digestive disease treatment.
  • Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
Show all investments...

HTGF (High-Tech Gruenderfonds)
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 3 investments in Switzerland Medical startups

High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in various sectors.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 781
  • Round size: Seed $790k–$6.9M; Pre-Seed $841k–$2.8M; Series A $3M–$31M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — raised $515M in 2022

Portfolio highlights

  • Selfapy — Selfapy offers a therapy support tool that helps recognize negative patterns of thought and train new behavior. Selfapy is your guided, self-help online course against depression with a personal psychologist as a companion.
  • Smartblue — Smartblue develops and runs software and processes to monitor and optimize zero emission energy systems. As a hardware independent specialist Smartblue delivers a software service for the maintenance, life-cycle management, production forecasting and remote control of photovoltaic and energy storage systems all together in one centralized “SmartControl” Operations and Control Center web application. We help our customers drive down overall operational cost through automation, smart failure detection and big data analysis on imminent defects.
  • OMEICOS Therapeutics — OMEICOS Therapeutics is developing a novel, first-in-class, small molecule utilizing a new Mode of Action. OMEICOS' novel therapeutic strategy is based upon the discovery of natural metabolites of omega-3 fatty acids that mediate a strong anti-arrhythmic effect. In contrast to all other anti-arrhythmic drugs, OMEICOS' substances activatean endogenous cardio-protective signaling pathway that not only stabilizes the heart rhythm but shall provide curative effects to the diseased organ by preventing its electrical and structural remodeling.
Show all investments...

Yellowstone Holding
VC Fund · Versoix, Geneve, Switzerland · 2 investments in Switzerland Medical startups

Yellowstone Holding promoting new innovative products or technologies from Switzerland to the Asia market via our strong connections.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: Switzerland, Taiwan, Germany

Investor stats

  • Total investments: 7
  • Lead/follow: no public data

Portfolio highlights

  • Medyria — Medyria is a Swiss medtech startup that engineers technologies for cardiovascular catheter navigation and sensing. They develop a unique guiding and sensing medical device based on proprietary Blood Flow Velocity Sensor technology. The TrackCath System is designed to be cost-effective and safe during EVAR procedures.Medyria's goal is todevelop devices that enable safer and more effective endovascular procedures. It was founded in 2014 and is based in Winterthur, Zurich, Switzerland.
  • CryoTherapeutics — CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries.
  • ZuriMED Technologies AG — Revolutionizing Soft Tissue Repair in Sports Medicine through Innovative Technologies
Show all investments...

Grazia Equity
VC Fund · Stuttgart, Baden-Wurttemberg, Germany · 2 investments in Switzerland Medical startups

Grazia Equity is a venture Capital firm investing in innovative, technology driven startups with high potential.Based in Stuttgart (Germany), Grazia has been supporting a large number of mostly young companies, often from their foundation to the Initial Public Offering or eventual sale. In contrast to other venture capital firms, theypredominantly work with their own capital that they invest as entrepreneurs.

Show more...

Investment focus

  • Industry: Internet, E-Commerce, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: Germany, United States, Switzerland

Investor stats

  • Total investments: 83
  • Round size: Seed $1.1M–$8M; Series A $1.1M–$53M; Series B $4M–$59M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • GYANT — Create more capacity to care. Fabric is the care enablement system powering healthcare to move faster, work smarter, and deliver better care.
  • XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
  • Mister Spex — Mister Spex is an online store that sells various brands of glasses and contact lenses in Germany. Its product range includes over 5000 different glasses, sunglasses, sports eyewear, and contact lenses from more than 60 brands and designers.The store’s offerings include sports labels such as Adidas, Carrera, Lacoste, and Oakley to designer brandssuch as Burberry, Calvin Klein, Dolce&Gabbana, Gucci, Jil Sander, Prada, Roberto Cavalli, Tom Ford, and Versace.Mister Spex was launched in 2007 and its operations are headquartered in Berlin, Germany. It also operates its own websites in France, Spain, Austria, Switzerland, the Netherlands, and Great Britain.
Show all investments...

ORTHO INNOVATIONS
VC Fund · Phoenix, Arizona, United States · 2 investments in Switzerland Medical startups

Ortho Innovations is a manufacturer of orthopedic products. The company's products are the elbow brace, knee brace, hyperflexion elbow, wrist, flexion-extension, wrist pronation, supination, and hip abduction orthosis.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • KetoSwiss — KetoSwiss is a Swiss-based BioTech startup that strives to bring ketone bodies back into the modern world to combat diseases. It develops and clinically tests a novel nutraceutical/medical food for the dietary preventive therapy of higher-frequency migraines and possibly other related neurological diseases characterized by a metabolicdysfunction (such as Alzheimer's disease). KetoSwiss is headquartered at the Technologie Park Basel, in Basel Switzerland, where it is part of a dynamic scientific and entrepreneurial community composed of world-leading academic research laboratories, flourishing life sciences spin-offs and s world-leading biotech-startup-ecosystem.
Show all investments...

Healthspan Capital
VC Fund · El Cerrito, California, United States · 2 investments in Switzerland Medical startups

Healthspan Capital is an early-stage longevity venture capital firm that invests in biotechnology startups developing therapies to slow or reverse aging.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 7
  • Lead/follow: no public data

Portfolio highlights

  • KetoSwiss — KetoSwiss is a Swiss-based BioTech startup that strives to bring ketone bodies back into the modern world to combat diseases. It develops and clinically tests a novel nutraceutical/medical food for the dietary preventive therapy of higher-frequency migraines and possibly other related neurological diseases characterized by a metabolicdysfunction (such as Alzheimer's disease). KetoSwiss is headquartered at the Technologie Park Basel, in Basel Switzerland, where it is part of a dynamic scientific and entrepreneurial community composed of world-leading academic research laboratories, flourishing life sciences spin-offs and s world-leading biotech-startup-ecosystem.
  • ImmuneAGE Bio — ImmuneAGE Bio is the first drug discovery platform company focused on immune system rejuvenation.
  • Reservoir Neuroscience — Reservoir Neuroscience is a biopharma company that develops novel therapeutics to repair dysfunctional blood vessels in the brain. Reservoir Neuroscience was founded in 2019 and is based in Emeryville, California.
Show all investments...

Reference Capital SA
VC Fund · Geneva, Geneve, Switzerland · 2 investments in Switzerland Medical startups

Reference Capital is a privately held advisory firm dedicated to researching and investing in disruptive technologies which will transform the world we live in. Our team is composed of seasoned VC investors and family office managers primarily based in Geneva, Switzerland.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series C, Series B
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 54
  • Lead/follow: no public data

Portfolio highlights

  • Wayve — Wayve are pioneering an AI-centric approach to self-driving, inspired by our vision of a smarter, safer and more sustainable world.
  • All Day Kitchens — Virtual Kitchen operates as a platform that empowers restaurants to take full advantage of the delivery opportunity. Its delivery-optimized kitchens and technology unlock delivery coverage with minimal upfront investment. The company was founded in 2018 and is headquartered in San Francisco, California.
  • Kingdom Supercultures — Kingdom Supercultures create microbial cultures that help food manufacturers to create new foods with boosted benefits. It re-assembles nature's microbes into new combinations, creating plant-based foods that taste like dairy, low-alcohol beverages with full flavor, and natural preservatives that work as well as artificial ones.They workwith clients across diverse industries including food, beverage, personal care, beauty, and more. Their technology comprises an expansive biobank of GRAS microbial strains, high-resolution strain characterization, and new algorithms for predicting and assembling microbial communities.
Show all investments...

Calm/Storm Ventures
VC Fund · Vienna, Wien, Austria · 2 investments in Switzerland Medical startups

Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.

Show more...

Investment focus

  • Industry: Health Care, Wellness, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, Germany, Austria

Investor stats

  • Total investments: 113
  • Lead/follow: no public data

Portfolio highlights

  • aiomics — Aiomics | Back to your calling.Across Europe, healthcare providers lose hours every day to fragmented documentation—handwritten notes, scanned PDFs, dictations, disconnected IT systems. The result: burnout, missed revenue, and patients feeling like they’re asked the same question three times.Aiomics changes this. Our AI-driven co-pilot capturesevery clinical detail—speech, handwriting, digital notes—and validates it in real time with a human-in-the-loop process. Interactive checklists surface missing information before the patient leaves, and audit-ready records flow straight back into existing systems. Built for GDPR, MDR, and the EU AI Act from day one, Aiomics makes documentation complete, compliant, and instantly usable.We don’t replace EHRs—we make them better. From admission and discharge reports to insurer forms, from therapist briefings to patient-friendly letters, Aiomics turns paperwork from a burden into an asset. For providers, that means fewer errors, faster reimbursements, and—most importantly—more time at the bedside.Our mission: to empower healthcare professionals by removing administrative burdens and elevating their decision-making with trusted AI guidance—so they can reconnect with why they chose this vocation in the first place.Who we are: Aiomics is co-founded by Dr. Sven Jungmann, a physician with frontline experience of administrative overload; Dr. Nikita Tarasov, a physicist and data scientist; and a lawyer who scaled one of Europe’s largest digital service companies. Together, we unite empathy, technical mastery, and regulatory expertise to build the trusted co-pilot for Europe’s healthcare providers.
  • ThinkSono — ThinkSono is a company at the cutting edge of medicine and technology.
  • Nolea Health — As a clinician with Nolea you can set your own schedule, work with as many healthcare companies as you want, hold all of your credentials in one single sharable wallet, access new educational resources, and receive community feedback.
Show all investments...

Novo Holdings
VC Fund · Hellerup, Hovedstaden, Denmark · 2 investments in Switzerland Medical startups

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 335
  • Round size: Series A $9M–$120M; Series B $12M–$130M; Series C $30M–$118M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $165M in 2018

Portfolio highlights

  • AlloCure — AlloCure is a biotechnology company, develops cell therapies for the treatment of various kidney diseases, organ transplants, and multi-organ injuries. It offers biological therapeutics for acute kidney injuries. AlloCure is based in Burlington, Massachusetts. It has operations in Salt Lake City, Utah, and Hamburg, Germany.The company isdedicated to the development of off-the-shelf biological therapies to treat serious and debilitating diseases that afflict millions of people around the world. AlloCure's unique technology uses processed cells derived from human bone marrow to treat a wide variety of diseases. AlloCure was founded on the unique and proprietary technology developed by Dr. Christof Westenfelder and Dr. Axel Zander. Westenfelder and Zander are world-renowned scientists who have dedicated their careers to developing effective therapies for kidney disease. AlloCure has operations in Salt Lake City Utah and Hamburg Germany.
  • PTC Therapeutics — Translating Science. Transforming Lives.
  • Freeline — A leading biotechnology company focused on innovative liver directed gene therapies for bleeding disorders and other debilitating, chronic diseases
Show all investments...

Ecosystem Ventures
VC Fund · San Francisco, California, United States · 2 investments in Switzerland Medical startups

Ecosystem Ventures is a venture capital investment and strategic consulting firm that offers related consultation services to seed stage companies. It is dedicated to building sustainable companies around significant technologies and innovative business ideas. The firm invests in companies during the seed round and works with entrepreneurs to grow their businesses until the first large institutional investment (Series A). It offers its business consulting support and services in the American, Indian, and European markets. Founded in 2005, Ecosystem Ventures is based in San Francisco, California.

Show more...

Investment focus

  • Industry: Mobile Apps, Mobile, Finance
  • Stage:Seed, Series A, Angel
  • Geography: United States, India, Switzerland

Investor stats

  • Total investments: 27
  • Round size: Seed $203k–$2M; Angel $500k–$1M; Series A $700k–$15M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — last raise in 2009

Portfolio highlights

  • GeoIQ.io — GeoIQ helps India's leading brands make smarter location decisions with AI-powered site selection, territory planning, and consumer profiling.
  • SpeEdLabs — SpeEdLabs is to provide a top-notch, technology-based Learning and Practice platform to students at an affordable price, thus empowering every student to grow into their full potential.
  • Mindler — Discover your perfect career, stream, college & course with India's leading career counsellors. Career counselling & guidance programs for school, college students & graduates.
Show all investments...

Medical VC funding in Switzerland at a glance

Stats across 707 deals from 541 investors.

541
investors
in Switzerland Medical startups
707
deals
in Switzerland Medical startups
$1.1M
median round
in Switzerland Medical startups
50%
lead investors
lead at least one round
36%
Grant
most common funding stage

Access all 541 VC funds in Switzerland Medical startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical VC Funds in Switzerland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 541 VC funds investing in Switzerland Medical startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists